The largest pooled analysis on this question, synthesizing data across multiple studies, found no statistically significant overall association between laxative use and colorectal cancer risk. But that headline number hides real complexity underneath: different types of laxatives carry different risk profiles, and separating the effect of laxatives from the effect of the constipation they treat has proven stubbornly difficult for researchers.
What Population Studies Have Found
A 2025 pooled analysis combining results from multiple studies reported an overall odds ratio of 0.95 for colorectal cancer among laxative users compared to non-users, meaning no meaningful increase or decrease in risk across laxative types taken together.1Oncology Letters. Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis That sounds reassuring, but individual studies have turned up more concerning findings when they separated laxatives by type. A case-control study found that people who regularly used non-fiber laxatives had roughly double the colorectal cancer risk of non-users, while fiber-based laxative users showed no increased risk at all.2PubMed Central. Laxative type in relation to colorectal cancer risk A prospective study tracking laxative use over a decade found that even low-frequency non-fiber laxative use was associated with about a 40 to 50 percent increase in colorectal cancer risk.3PubMed Central. A prospective study of bowel movement frequency, constipation, and laxative use on colorectal cancer risk A Japanese cohort study echoed this, finding that frequent laxative users (twice a week or more) had nearly three times the colon cancer risk of non-users.4PubMed. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study
These numbers look alarming in isolation, but they sit alongside the pooled analysis showing no significant link overall. The contradiction comes down to what gets lumped together. When researchers treat all laxatives as one category, the elevated risks from certain types get diluted by the apparently neutral or even protective effects of others. The same pooled analysis that found no overall risk actually found that fiber-based laxatives were associated with a reduced cancer risk, with an odds ratio of 0.74.1Oncology Letters. Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis So the answer depends heavily on which laxative you’re talking about.
Why Separating Laxatives From Constipation Is So Hard
The central problem haunting this research is confounding. People who take laxatives are, by definition, people who have trouble with their bowels. That means researchers are trying to figure out whether it’s the medicine or the underlying condition doing the damage. A 2024 critical review pointed out that many studies linking stimulant laxatives to harm failed to control for basic factors like age and diseases that independently cause both constipation and gut damage, particularly diabetes.5PubMed Central. Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge Both laxative use and cancer incidence rise with age, so unless a study carefully accounts for that overlap, an apparent laxative-cancer link could just be reflecting the fact that older people use more laxatives and get more cancer.
A large Swedish case-control study tried to cut through this problem using a clever approach: comparing siblings. After standard statistical adjustments, chronic constipation showed a modest link to colorectal cancer, with about a 10 percent increase in odds. But when researchers compared constipated individuals to their own siblings, who shared similar genetics and early-life environments, that association essentially vanished.6Clinical Gastroenterology and Hepatology. Chronic Constipation as a Risk Factor for Colorectal Cancer: Results From a Nationwide, Case-Control Study That finding suggests at least some of the observed constipation-cancer link, and by extension the laxative-cancer link, reflects shared background factors rather than a direct cause.
Stimulant Laxatives and Anthraquinones
Stimulant laxatives are the category that has generated the most concern. These include senna-based products (the active compounds are called sennosides) and anthraquinone-containing plants like cascara, aloe, and rhubarb root. They work by irritating the intestinal lining to trigger contractions. That mechanism has naturally raised the question of whether repeated irritation could promote abnormal cell growth over time.
Animal studies have produced mixed signals. When rats were fed high doses of senna and cascara glycosides, the compounds did not cause precancerous lesions on their own. But in rats already exposed to a chemical carcinogen, the highest doses of these glycosides appeared to act as weak promoters, slightly amplifying the damage the carcinogen had already started.7Cancer Letters. Evaluation of the potential carcinogenic activity of Senna and Cascara glycosides for the rat colon A separate review of the toxicology literature concluded that sennosides have very low toxicity in rats and that their genotoxic activity in laboratory tests was classified as weak in the cases where it was detectable at all, with no established genotoxic risk for patients using senna-containing laxatives.8PubMed Central. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity?
Cell-level studies have explored a subtler possibility. When sennosides are given acutely, they trigger programmed cell death in the colon lining, which is generally a protective response: damaged cells eliminate themselves before they can become cancerous. But in people with severe melanosis coli (a condition caused by chronic anthraquinone use), this cell-death mechanism appeared to be blunted, with longer intestinal crypts suggesting the cells were surviving when they normally should not.9PubMed. Apoptosis induction by sennoside laxatives in man; escape from a protective mechanism during chronic sennoside use? That said, a direct study measuring cell proliferation rates in the colon after treatment with sennosides, bisacodyl, and sodium picosulfate found no significant increase, leading its authors to conclude that stimulant laxatives should not be regarded as tumor-promoting.10PubMed. Effects of ‘contact laxatives’ on intestinal and colonic epithelial cell proliferation
The concern is sharper for long-term heavy use. A review article on anthranoid laxatives concluded that while short-term use is generally safe, long-term use cannot be recommended, given that both laboratory and human studies have suggested tumor-promoting activities.11PubMed. Anthranoid laxatives and their potential carcinogenic effects One prospective study of patients undergoing colonoscopy calculated a relative risk of about 3 for colorectal cancer among people who had chronically abused anthranoid laxatives, using melanosis coli as a marker for prolonged use.12Gut. Anthranoid laxative abuse–a risk for colorectal cancer? That is a meaningfully elevated risk, though the study relied on endoscopy patients, who are not representative of the general population.
Aloe Vera Whole-Leaf Extract
Aloe vera deserves separate mention because many people think of it as a gentle, natural product rather than a laxative. The whole-leaf extract contains anthraquinones (the same class of compounds in senna and cascara) and acts as an intestinal irritant. A National Toxicology Program study in rats found that aloe vera whole-leaf extract produced clear evidence of carcinogenic activity, with significantly higher rates of intestinal tumors in both male and female rats at the two highest doses tested.13Toxicological Sciences. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats This finding applies to the whole-leaf extract, which includes the latex layer where anthraquinones concentrate, not to decolorized aloe vera gel used in skin products. Still, it undercuts the assumption that “natural” means harmless.
Osmotic Laxatives May Be Protective
Osmotic laxatives work by drawing water into the intestine, softening stool without directly stimulating the gut wall. Polyethylene glycol (PEG), the active ingredient in many over-the-counter products, has produced surprisingly positive results in cancer research. In rats given a chemical that induces colon tumors, dietary PEG reduced tumor incidence from 70 percent to 10 percent, and no cancers at all were detected in the PEG-fed group.14PubMed. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats Animal studies are not human trials, but human observational data has pointed in the same direction: a study of patients undergoing colonoscopy found that prior use of a PEG-containing laxative was more common in people without tumors, with roughly half the odds of adenomas compared to non-users.15PubMed. Polyethylene glycol and prevalence of colorectal adenomas
The proposed explanation is mechanical rather than chemical. PEG is not absorbed or fermented in the gut. By increasing the water content of stool, it may dilute carcinogens and speed their transit through the colon, reducing the time the intestinal lining is exposed to them. Whatever the mechanism, PEG is one of the laxatives most strongly recommended by current clinical guidelines for chronic constipation.16PubMed Central. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation
Phenolphthalein Got Pulled for Good Reason
One laxative ingredient has been definitively removed from the market over cancer concerns. Phenolphthalein, once the active ingredient in many popular over-the-counter laxatives, showed clear evidence of carcinogenic activity in two-year feeding studies in rodents conducted by the National Toxicology Program. The doses used in those studies were comparable to what humans might take. In 1999, the U.S. FDA reclassified phenolphthalein as not generally recognized as safe and effective, and manufacturers reformulated their products, typically switching to bisacodyl or senna. If you’re using a modern commercial laxative, it almost certainly does not contain phenolphthalein, but it’s worth checking older or imported products.
Fiber-Based Laxatives Sent Mixed Signals
You would expect fiber laxatives to be the safest option, and the overall data supports that. The pooled analysis found fiber-based laxatives associated with a roughly 26 percent reduction in colorectal cancer risk.1Oncology Letters. Effect of laxative use and laxative type on colorectal cancer risk: A pooling up analysis and evidence synthesis The case-control study that found doubled risk with non-fiber laxatives found no association at all with fiber-based ones.2PubMed Central. Laxative type in relation to colorectal cancer risk
But one randomized trial complicated the picture. In a European study of patients who had already had colorectal adenomas removed, those assigned to take ispaghula husk (a soluble fiber supplement commonly sold as psyllium) had significantly higher adenoma recurrence than those given placebo, with an adjusted odds ratio of 1.67. The fiber group saw adenomas return in about 29 percent of participants, compared to 20 percent on placebo.17The Lancet. Effect of calcium and fibre with reference to colon and rectal adenomas: a randomised trial The effect was strongest in patients who were already getting a lot of calcium in their diets. This was a specific type of fiber given to a specific high-risk population, so it should not be taken as evidence that fiber in general causes polyps. But it is a reminder that “fiber” is not one substance, and the form, dose, and patient population all matter.
What Melanosis Coli Does and Does Not Mean
If you use anthraquinone-containing laxatives (senna, cascara, aloe) for months, the lining of your colon can develop a dark brown or black pigmentation called melanosis coli. The staining comes from pigment-laden cells called macrophages accumulating in the gut wall. It looks dramatic on a colonoscopy, and for years there was debate about whether it signals cancer risk.
Recent large studies have found that polyps and adenomas are detected at higher rates in patients with melanosis coli. A large retrospective cohort study found adenoma detection rates of about 30 percent in melanosis patients compared to 24 percent in those without it.18PubMed. Melanosis coli: a contrast effect or an oncogenic effect? A large-scale retrospective cohort study A separate study found that severe melanosis was associated with even higher adenoma detection, particularly for larger lesions.19PubMed Central. Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma
But there’s a strong argument that this is an optical illusion rather than a biological one. Polyps tend to resist the dark pigmentation, so they stand out visually against the stained background like a light spot on a dark canvas. A study of cancer patients found melanosis coli in only about 12 percent of cases and concluded the two conditions were not meaningfully related.20PubMed Central. Melanosis coli in patients with colon cancer An older retrospective study found no significant increase in colorectal cancer rates among laxative users or melanosis patients, though it did find more adenomas, and the authors specifically noted that the easier visual detection of polyps against darkened mucosa likely inflated the numbers.21PubMed. Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma If melanosis coli actually helps doctors find polyps that might otherwise be missed, it could ironically be protective by improving screening outcomes.
Laxative Misuse and the Gut Microbiome
Occasional or guideline-directed laxative use is very different from the kind of chronic misuse seen in some eating disorders. Research on individuals with bulimia nervosa or binge-eating disorder who reported laxative use found significant reductions in gut microbial diversity across multiple measures, along with reduced abundance of several specific bacterial groups.22PubMed Central. Laxative abuse is associated with a depleted gut microbial community structure among females and males with binge-eating disorder or bulimia nervosa: The Binge Eating Genetics Initiative (BEGIN) A depleted microbiome has been linked to inflammation and impaired immune surveillance in the gut, both of which are relevant to cancer development over time. The study was not designed to track cancer outcomes, but the findings reinforce that long-term laxative abuse carries biological costs that go beyond the well-known risks of dehydration and electrolyte imbalance.
Where Current Clinical Guidelines Stand
Despite the scattered warning signals in the research, medical guidelines have not backed away from recommending laxatives for people who need them. The joint American Gastroenterological Association and American College of Gastroenterology guideline on chronic constipation makes strong recommendations for PEG, sodium picosulfate, and several prescription medications. It gives conditional (but still positive) recommendations for senna, fiber, lactulose, and magnesium oxide.16PubMed Central. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation The conditional label for senna reflects the less robust safety data for very long-term use, not evidence of proven harm at normal doses.
In practical terms, this means the clinical community views the benefits of treating constipation as outweighing theoretical cancer risks for the vast majority of patients. Untreated chronic constipation comes with its own set of problems, and there is no evidence that short-term or moderate use of any currently available laxative raises cancer risk in a clinically significant way. The concern is concentrated on years of heavy, unsupervised use of anthraquinone-type stimulant laxatives, and even there the evidence is suggestive rather than definitive.
How to Think About Your Own Risk
If you use an osmotic laxative like PEG for occasional or chronic constipation, the current evidence gives you no reason to worry about cancer and some reason to think it could be mildly beneficial for your colon. If you rely on senna or bisacodyl for short stints, the data is reassuring. If you have been taking anthraquinone laxatives daily for years without medical supervision, that is the scenario where the research raises genuine flags, and a conversation with your doctor about switching to a different type makes sense.
Herbal products containing aloe latex, cascara, or senna marketed as “natural cleansers” or “detox teas” deserve more scrutiny than their branding suggests. These contain the same anthraquinone compounds that have raised concerns in formal studies, sometimes at poorly standardized doses. The 2024 critical review of stimulant laxative safety noted that many studies reporting harm failed to distinguish between pharmaceutical-grade senna taken at recommended doses and unregulated herbal preparations taken in unknown quantities.5PubMed Central. Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge The dose, the formulation, and how long you take it all matter more than whether something is called “natural” or “pharmaceutical.” If you’re taking any laxative regularly, knowing which type it is and talking to your doctor about whether that’s the right long-term choice is a better use of your concern than blanket worry about a laxative-cancer link that, for most products and most people, does not appear to exist.